UNIKARE BIOSCIENCE SL
Company details
- Active NIF/CIF: B01563741
-
-
-
-
Address: Albert Einstein Kalea, 15, 01510 Vitoria-Gasteiz, Araba, España See in map
-
-
Featured products:
Turnover UNIKARE BIOSCIENCE SL
More information on UNIKARE BIOSCIENCE SL
-
08/06/2023 | BORME act no.: 259325 | Register: ARABA/ÁLAVAModificaciones estatutarias
-
08/06/2023 | BORME act no.: 259325 | Register: ARABA/ÁLAVAAmpliacion del objeto social
-
31/12/2019 | BORME act no.: 544494 | Register: ARABA/ÁLAVACeses/Dimisiones
-
24/08/2018 | BORME act no.: 349351 | Register: ARABA/ÁLAVAAmpliación de capital
-
24/08/2018 | BORME act no.: 349351 | Register: ARABA/ÁLAVAModificaciones estatutarias
-
23/02/2018 | BORME act no.: 87953 | Register: ARABA/ÁLAVAConstitución
-
23/02/2018 | BORME act no.: 87953 | Register: ARABA/ÁLAVANombramientos
Other information
The CIF assigned to UNIKARE BIOSCIENCE SL is B01563741, and its business status is active. The company is engaged in an economic activity classified within the CNAE 2042 - Fabricación de perfumes y cosméticos. In addition, its SIC identification - also defines it.
UNIKARE BIOSCIENCE SL employs a team of Between 1 and 9 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Araba/álava, and has 3 executive positions. Its most recent announcement in the Borme was published on 08/06/2023, while its last deposit of ordinary annual accounts is for the 2023 fiscal year.
To access the contact information of UNIKARE BIOSCIENCE SL, such as the telephone number, postal address, or website, visit the Company Data module.
If you require more details about UNIKARE BIOSCIENCE SL, we invite you to consult one of our available financial reports, the company's Annual Accounts, or to check its payment incidents in the RAI delinquency file.
The financial, business, and legal information provided about UNIKARE BIOSCIENCE SL is extracted from official sources and is updated daily.
Do you want to know more about UNIKARE BIOSCIENCE SL??
Find out more about this company by consulting these reports: